NCT02382094View on ClinicalTrials.gov

Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

April 30, 2009

Study Completion Date

July 31, 2012

Conditions
Prostate Cancer
Interventions
DRUG

Bicalutamide

All Listed Sponsors
lead

Karolinska University Hospital

OTHER

NCT02382094 - Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy | Biotech Hunter | Biotech Hunter